Merck Tbk PT (MERK.JK) Stock Price

Merck Tbk PT Price

CLOSED
3,960.00IDR+30.00 (+0.76 %)
Market closed

Over the last 19 years Merck Tbk PT grew revenue by 4.9% annually, reaching 1.20 T IDR. Earnings per share have grown at 3.2% per year over the last 16 years. For Merck Tbk PT, the net margin of 20.3% is up versus 12.4% a few years ago. At today's price the dividend yield works out to roughly 4.29%. The payout ratio is around 31% of earnings. The stock trades about 42% above its 52-week low.

Merck Tbk PT stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Merck Tbk PT over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Merck Tbk PT stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Merck Tbk PT's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Merck Tbk PT Stock Price History
DateMerck Tbk PT Price
8/7/20263,960.00 IDR
8/6/20263,930.00 IDR
8/5/20263,900.00 IDR
8/4/20263,960.00 IDR
8/3/20263,930.00 IDR
7/31/20263,800.00 IDR
7/30/20263,940.00 IDR
7/29/20263,900.00 IDR
7/28/20263,920.00 IDR
7/27/20264,020.00 IDR
7/24/20264,000.00 IDR
7/23/20264,000.00 IDR
7/22/20264,000.00 IDR
7/21/20264,000.00 IDR
7/20/20264,000.00 IDR
7/17/20263,860.00 IDR
7/16/20263,840.00 IDR
7/15/20263,800.00 IDR
7/14/20263,760.00 IDR
7/13/20263,740.00 IDR
7/10/20263,740.00 IDR
7/9/20263,730.00 IDR
7/8/20263,730.00 IDR
7/7/20263,690.00 IDR
7/6/20263,690.00 IDR
7/3/20263,720.00 IDR
7/2/20263,670.00 IDR
7/1/20263,660.00 IDR
6/30/20263,600.00 IDR
6/29/20263,670.00 IDR
6/26/20263,590.00 IDR
6/25/20263,640.00 IDR
6/24/20263,570.00 IDR
6/23/20263,640.00 IDR
6/22/20263,550.00 IDR
6/19/20263,630.00 IDR
6/18/20263,570.00 IDR
6/17/20263,670.00 IDR
6/15/20263,690.00 IDR
6/12/20263,500.00 IDR
6/11/20263,420.00 IDR
6/10/20263,620.00 IDR
6/9/20263,610.00 IDR
6/8/20263,580.00 IDR
6/5/20263,860.00 IDR
6/4/20263,880.00 IDR
6/3/20263,900.00 IDR
6/2/20263,980.00 IDR
5/29/20263,900.00 IDR
5/28/20264,010.00 IDR
5/27/20264,010.00 IDR
5/26/20264,010.00 IDR
5/25/20264,010.00 IDR
5/22/20264,040.00 IDR
5/21/20263,980.00 IDR
5/20/20263,900.00 IDR
5/19/20263,930.00 IDR
5/18/20264,130.00 IDR
5/15/20264,170.00 IDR
5/14/20264,170.00 IDR
5/13/20264,170.00 IDR
5/12/20264,020.00 IDR
5/11/20264,280.00 IDR
5/8/20264,270.00 IDR
5/7/20264,280.00 IDR
5/6/20264,160.00 IDR
5/5/20264,380.00 IDR
5/4/20264,380.00 IDR
4/30/20264,200.00 IDR
4/29/20264,300.00 IDR
4/28/20264,130.00 IDR
4/27/20263,840.00 IDR
4/24/20263,720.00 IDR
4/23/20263,740.00 IDR
4/22/20263,650.00 IDR
4/21/20263,640.00 IDR
4/20/20263,620.00 IDR
4/17/20263,620.00 IDR
4/16/20263,650.00 IDR
4/15/20263,630.00 IDR
4/14/20263,600.00 IDR
4/13/20263,570.00 IDR
4/10/20263,550.00 IDR
4/9/20263,450.00 IDR
4/8/20263,360.00 IDR
4/7/20263,360.00 IDR
4/6/20263,360.00 IDR
4/2/20263,400.00 IDR
4/1/20263,500.00 IDR
3/31/20263,070.00 IDR
3/30/20263,020.00 IDR
3/27/20263,070.00 IDR
3/26/20263,080.00 IDR
3/25/20263,110.00 IDR
3/17/20263,040.00 IDR
3/16/20263,070.00 IDR
3/13/20263,070.00 IDR
3/12/20263,110.00 IDR
3/11/20263,080.00 IDR
3/10/20263,110.00 IDR
3/9/20263,080.00 IDR
3/6/20263,090.00 IDR
3/5/20263,150.00 IDR
3/4/20263,090.00 IDR
3/3/20263,200.00 IDR
3/2/20263,150.00 IDR
2/27/20263,150.00 IDR
2/26/20263,130.00 IDR
2/25/20263,190.00 IDR
2/24/20263,190.00 IDR
2/23/20263,200.00 IDR
2/20/20263,170.00 IDR
2/19/20263,170.00 IDR
2/18/20263,180.00 IDR
2/13/20263,200.00 IDR
2/12/20263,200.00 IDR
2/11/20263,170.00 IDR
2/10/20263,170.00 IDR
2/9/20263,180.00 IDR
2/6/20263,180.00 IDR
2/5/20263,210.00 IDR
2/4/20263,210.00 IDR
2/3/20263,200.00 IDR
2/2/20263,200.00 IDR
1/30/20263,150.00 IDR
1/29/20263,100.00 IDR
1/28/20263,070.00 IDR
1/27/20263,270.00 IDR
1/26/20263,300.00 IDR
1/23/20263,240.00 IDR
1/22/20263,260.00 IDR
1/21/20263,320.00 IDR
1/20/20263,330.00 IDR
1/19/20263,320.00 IDR
1/2/20263,290.00 IDR
12/30/20253,350.00 IDR
12/29/20253,360.00 IDR
12/24/20253,290.00 IDR
12/23/20253,280.00 IDR
12/22/20253,280.00 IDR
12/19/20253,290.00 IDR
12/18/20253,290.00 IDR
12/17/20253,300.00 IDR
12/16/20253,270.00 IDR
12/15/20253,300.00 IDR
12/12/20253,240.00 IDR
12/11/20253,140.00 IDR
12/10/20253,220.00 IDR
12/9/20253,220.00 IDR
12/8/20253,230.00 IDR
12/5/20253,210.00 IDR
12/4/20253,200.00 IDR
12/3/20253,190.00 IDR
12/2/20253,150.00 IDR
12/1/20253,180.00 IDR
11/28/20253,170.00 IDR
11/27/20253,160.00 IDR
11/26/20253,140.00 IDR
11/25/20253,100.00 IDR
11/24/20253,080.00 IDR
11/21/20253,040.00 IDR
11/20/20253,100.00 IDR
11/19/20253,100.00 IDR
11/18/20253,100.00 IDR
11/17/20253,080.00 IDR
11/14/20253,090.00 IDR
11/13/20253,080.00 IDR
11/12/20253,090.00 IDR
11/11/20253,110.00 IDR
11/10/20253,110.00 IDR
11/7/20253,100.00 IDR
11/6/20253,100.00 IDR
11/5/20253,060.00 IDR
11/4/20253,030.00 IDR
11/3/20253,110.00 IDR
10/31/20252,860.00 IDR
10/30/20252,870.00 IDR
10/29/20252,870.00 IDR
10/28/20252,810.00 IDR
10/27/20252,870.00 IDR
10/24/20252,860.00 IDR
10/23/20252,850.00 IDR
10/22/20252,810.00 IDR
10/21/20252,810.00 IDR
10/20/20252,800.00 IDR
10/17/20252,800.00 IDR
10/16/20252,840.00 IDR
10/15/20252,820.00 IDR
10/14/20252,840.00 IDR
10/13/20252,830.00 IDR
10/10/20252,810.00 IDR
10/9/20252,790.00 IDR
10/8/20252,800.00 IDR
10/7/20252,820.00 IDR
10/6/20252,860.00 IDR
10/3/20252,840.00 IDR
10/2/20252,820.00 IDR
10/1/20252,830.00 IDR
9/30/20252,860.00 IDR
9/29/20252,880.00 IDR
9/26/20252,860.00 IDR
9/25/20252,860.00 IDR
9/24/20252,830.00 IDR
9/23/20252,840.00 IDR
9/22/20252,800.00 IDR
9/19/20252,800.00 IDR
9/18/20252,790.00 IDR
9/17/20252,800.00 IDR
9/16/20252,800.00 IDR
9/15/20252,810.00 IDR
9/12/20252,810.00 IDR
9/11/20252,810.00 IDR
9/10/20252,800.00 IDR
9/9/20252,810.00 IDR
9/8/20252,820.00 IDR
9/4/20252,800.00 IDR
9/3/20252,790.00 IDR
9/2/20252,810.00 IDR
9/1/20252,810.00 IDR
8/29/20252,800.00 IDR
8/28/20252,830.00 IDR
8/27/20252,810.00 IDR
8/26/20252,820.00 IDR
8/25/20252,820.00 IDR
8/22/20252,800.00 IDR
8/21/20252,800.00 IDR
8/20/20252,800.00 IDR
8/19/20252,790.00 IDR
8/15/20252,790.00 IDR
8/14/20252,810.00 IDR
8/13/20252,810.00 IDR
8/12/20252,810.00 IDR
8/11/20252,800.00 IDR
Access this data via the Eulerpool API
Get Free API Key

Merck Tbk PT Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
611.96 B IDR
47.13 B IDR
1.16 T IDR
Jan 1, 2019
744.63 B IDR
125.59 B IDR
78.26 B IDR
Jan 1, 2020
655.85 B IDR
108.53 B IDR
71.90 B IDR
Jan 1, 2021
1.06 T IDR
191.53 B IDR
131.66 B IDR
Jan 1, 2022
1.12 T IDR
239.07 B IDR
179.84 B IDR
Jan 1, 2023
961.43 B IDR
199.73 B IDR
178.24 B IDR
Jan 1, 2024
1.04 T IDR
192.96 B IDR
153.46 B IDR
Jan 1, 2025
1.20 T IDR
320.43 B IDR
243.90 B IDR

Merck Tbk PT Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 9, 2026, 8:18 PM
 
REVENUET IDR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB IDR
EBITB IDR
EBIT MARGIN%
NET INCOMET IDR
NET INCOME GROWTH%
DIV.IDR
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
0.800.920.931.190.860.981.031.160.610.740.661.061.120.961.041.20
5.8915.441.2428.40-27.7013.935.2211.77-47.0921.68-11.9262.295.66-14.517.8315.81
55.5552.4945.6445.6953.1150.4652.4050.8434.5943.4244.8637.4638.0241.6538.8446.84
441.97482.14424.44545.48458.46496.26542.19588.00211.69323.31294.21398.68427.59400.47402.67562.44
154.55278.63141.25230.03200.44186.51213.30208.4947.13125.60108.53191.53239.07199.73192.96320.43
19.4230.3315.1919.2723.2218.9720.6118.037.7016.8716.5517.9921.2620.7718.6126.69
0.120.230.110.180.180.140.150.141.160.080.070.130.180.180.150.24
-19.0294.59-53.3662.743.44-21.457.93-5.96704.08-93.27-8.1283.1136.59-0.89-13.9058.93
4,909.00446.408,270.003,570.006,250.009,800.00200.00275.002,825.00–130.00122.00240.00320.00320.00170.00
-8.24-90.911,752.60-56.8375.0756.80-97.9637.50927.27––-6.1596.7233.33–-46.88
448.00448.00448.00448.09448.12446.74448.00448.00448.00448.00448.00448.00448.00448.00448.00448.00
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Merck Tbk PT generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Merck Tbk PT retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Merck Tbk PT's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Merck Tbk PT has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Merck Tbk PT's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Merck Tbk PT stock margins

The Merck Tbk PT margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Merck Tbk PT. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Merck Tbk PT.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
34.59 %
7.70 %
190.10 %
Jan 1, 2019
43.42 %
16.87 %
10.51 %
Jan 1, 2020
44.86 %
16.55 %
10.96 %
Jan 1, 2021
37.46 %
17.99 %
12.37 %
Jan 1, 2022
38.02 %
21.26 %
15.99 %
Jan 1, 2023
41.65 %
20.77 %
18.54 %
Jan 1, 2024
38.84 %
18.61 %
14.80 %
Jan 1, 2025
46.84 %
26.69 %
20.31 %

Merck Tbk PT Stock Revenue, EBIT, Earnings per Share

The Merck Tbk PT earnings per share therefore indicates how much revenue Merck Tbk PT has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
1,365.98 IDR
105.20 IDR
2,596.71 IDR
Jan 1, 2019
1,662.13 IDR
280.35 IDR
174.68 IDR
Jan 1, 2020
1,463.94 IDR
242.26 IDR
160.50 IDR
Jan 1, 2021
2,375.88 IDR
427.51 IDR
293.89 IDR
Jan 1, 2022
2,510.27 IDR
533.65 IDR
401.42 IDR
Jan 1, 2023
2,146.06 IDR
445.82 IDR
397.86 IDR
Jan 1, 2024
2,314.17 IDR
430.72 IDR
342.55 IDR
Jan 1, 2025
2,680.06 IDR
715.25 IDR
544.41 IDR

Merck Tbk PT business model & stock analysis

Merck Tbk PT Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Merck Tbk PT historical P/E ratio, EBIT multiple, and P/S ratio

Merck Tbk PT annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Merck Tbk PT shares outstanding

The number of shares of Merck Tbk PT was 448 M in 2025. This indicates how many shares Merck Tbk PT is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
448.00 M Stocks
Jan 1, 2019
448.00 M Stocks
Jan 1, 2020
448.00 M Stocks
Jan 1, 2021
448.00 M Stocks
Jan 1, 2022
448.00 M Stocks
Jan 1, 2023
448.00 M Stocks
Jan 1, 2024
448.00 M Stocks
Jan 1, 2025
448.00 M Stocks

Merck Tbk PT stock splits

In Merck Tbk PT's history, there have been no stock splits.

Merck Tbk PT Dividend History

35 years of dividend payments

YearAnnual DividendYoY ChangePayments
2025170.00IDR↓ 46.9%1×
Jun 25, 2025170.00IDR↓ 46.9%1/1
2024320.00IDR 0.0%1×
2023320.00IDR↑ 33.3%1×
2022240.00IDR↑ 96.7%1×
2021122.00IDR↓ 6.2%1×
2020130.00IDR↓ 95.4%1×
20182,825.00IDR↑ 927.3%2×
2017275.00IDR↑ 175.0%1×
2016100.00IDR↓ 99.0%1×
20159,800.00IDR↑ 56.8%2×

Merck Tbk PT dividend history and estimates

In 2025, Merck Tbk PT paid a dividend amounting to 170.00 IDR. Dividend means that Merck Tbk PT distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2017
275.00 IDR
0.00 IDR
Jan 1, 2018
2,825.00 IDR
0.00 IDR
Jan 1, 2020
130.00 IDR
0.00 IDR
Jan 1, 2021
122.00 IDR
0.00 IDR
Jan 1, 2022
240.00 IDR
0.00 IDR
Jan 1, 2023
320.00 IDR
0.00 IDR
Jan 1, 2024
320.00 IDR
0.00 IDR
Jan 1, 2025
170.00 IDR
0.00 IDR

Merck Tbk PT dividend payout ratio

In 2025, Merck Tbk PT had a payout ratio of 31.23%. The payout ratio indicates the percentage of the company's profits that Merck Tbk PT distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
108.79 %
Jan 1, 2019
68.36 %
Jan 1, 2020
81.00 %
Jan 1, 2021
41.51 %
Jan 1, 2022
59.79 %
Jan 1, 2023
80.43 %
Jan 1, 2024
93.42 %
Jan 1, 2025
31.23 %
Price targets and forecasts for Merck Tbk PT are not yet available.

Merck Tbk PT shareholder structure

% Name
73.99174%
Merck Holding GmbH
Merck Holding GmbH
12.65891%
Emedia Export Company mbH
Emedia Export Company mbH
1.15627%
HMG Finance S.A.
HMG Finance S.A.
0.04223%
Niche Asset Management Limited
Niche Asset Management Limited

Merck Tbk PT Beneficial Ownership Filings (SEC 13D/G)

Free Float
13.3%
Float Shares
-
Shares Outstanding
-

Merck Tbk PT Executives and Management Board

6 members · avg. age 56 · 50 % women

Management

MT

Ms. Mei Ling Tang (58)

President Commissioner

–
EY

Ms. Evie Yulin (55)

President Director, Biopharma Director

–
MS

Mrs. Melisa Sandrianti (43)

Corporate Secretary

–
PS

Mr. Parulian Simanjuntak (78)

Independent Commissioner

–

Board of Directors

BN

Mr. Bambang Nurcahyo (52)

Finance Director

–
AW

Mr. Arryo Aritrixso Teguh Putranto Wachjuwidajat (50)

Plant Director

–

Frequently asked questions about Merck Tbk PT

Converted at the current exchange rate, the Merck Tbk PT share trades at 0.19 EUR (3,960.00 IDR).

No history available for Merck Tbk PT.

The revenue cannot currently be calculated for Merck Tbk PT.

The profit cannot currently be calculated for Merck Tbk PT.

The P/E ratio cannot be calculated for Merck Tbk PT at the moment.

The P/S cannot be calculated for Merck Tbk PT currently.

The Eulerpool Quality Score for Merck Tbk PT is 4/10.

The ISIN of Merck Tbk PT is ID1000136609. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Merck Tbk PT is MERK.JK. The ticker symbol is used to trade Merck Tbk PT shares on the stock exchange.

Over the past 12 months, Merck Tbk PT paid a dividend of 170.00 IDR . This corresponds to a dividend yield of about 4.29 %. For the coming 12 months, Merck Tbk PT is expected to pay a dividend of 170.00 IDR.

The current dividend yield of Merck Tbk PT is 4.29 %.

Merck Tbk PT pays a dividend, distributed in the months of , , , .

Merck Tbk PT paid dividends every year for the past 6 years.

For the upcoming 12 months, dividends amounting to 170.00 IDR are expected. This corresponds to a dividend yield of 4.29 %.

Merck Tbk PT is assigned to the 'Health' sector.

To receive the latest dividend of Merck Tbk PT from amounting to 170 IDR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Merck Tbk PT distributed 320 IDR as dividends.

The dividends of Merck Tbk PT are distributed in IDR.

All fundamentals and in-depth analysis of Merck Tbk PT

Our stock analysis for Merck Tbk PT stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck Tbk PT. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Merck Tbk PT Stock
Merck Tbk PT Revenue→
Merck Tbk PT Stock
Merck Tbk PT Net Income→
Merck Tbk PT Stock
Merck Tbk PT P/E→
Merck Tbk PT Stock
Merck Tbk PT P/S→
Merck Tbk PT Stock
Merck Tbk PT EBIT→
Merck Tbk PT Stock
Merck Tbk PT Dividend→
Merck Tbk PT Stock
Merck Tbk PT Directors Dealings→
Merck Tbk PT Stock
Merck Tbk PT Stocks→
Merck Tbk PT Stock
Merck Tbk PT Market capitalization→
Merck Tbk PT Stock
Merck Tbk PT Debt→
Merck Tbk PT Stock
Merck Tbk PT Liabilities→
Merck Tbk PT Stock
Merck Tbk PT Equity→
Merck Tbk PT Stock
Merck Tbk PT AAQS→
Merck Tbk PT Stock
Merck Tbk PT Employees→
Merck Tbk PT Stock
Merck Tbk PT ROE→
Merck Tbk PT Stock
Merck Tbk PT ROA→
Merck Tbk PT Stock
Merck Tbk PT ROCE→
Merck Tbk PT Stock
Merck Tbk PT News→
Merck Tbk PT Stock
Merck Tbk PT Analyst Price Targets→

Health Stocks

Merdury BiopharmaceuticalMerck KGaAMereo BioPharma GroupMerck & CoMeridian BioscienceMerchavia Holdings and InvestmentsMerit Medical SystemsMercator MedicalMesa LaboratoriesMera PharmaceuticalsMesoblastMenticeAll Stocks A–Z →